Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Many farmers undecided about BTV-3 vaccination, survey finds
There have been over 160 cases of BTV-3 in the current vector period.
Ruminant Health & Welfare publishes early findings from farmer survey.

There is hesitancy about bluetongue virus serotype 3 (BTV-3) vaccinations among farmers, initial findings from a survey looking at the impact of the outbreak on farmers suggest.

Over half of the farmers who responded said they remain undecided about vaccination, though a significant number, particularly sheep farmers, said that they plan to vaccinate before the next summer season.

The survey, which is being conducted by Ruminant Health & Welfare in collaboration with Flock Health Limited, the Agriculture and Horticulture Development Board (AHDB), and the University of Nottingham, has also revealed the impact that the outbreak is having on farmers.

Some have reported that it has become more difficult to sell their livestock. Another, who had experienced mortality on their farm due to bluetongue, described the experience as “horrible; physically, financially, mentally and emotionally.”

Alongside the survey, the Animal and Plant Health Agency is studying the impact of the virus on premises where it has been confirmed. Signs seen in infected animals include lameness, swollen faces, nose and mouth ulcers, drooling, breathing difficulties, nasal discharge, and mortality.

Fiona Lovatt, of Flock Health Limited, said: “We know that in Germany, the research shows a marked difference in outcomes between vaccinated and unvaccinated herds and flocks.

“Findings indicate that unvaccinated sheep flocks have experienced mortality rates as high as 30 per cent, whereas vaccinated flocks show significantly lower mortality, with some reporting only 1-2 per cent losses.

“We want to learn from this data and build a UK base of evidence that we can trust going forwards.”

Bluetongue is a notifiable disease. Suspected cases must be reported on 03000 200 301 in England or 03003 038 268 in Wales. In Scotland, suspected cases should be reported to the local field services office. Suspected cases in Northern Ireland should be reported to the DAERA Helpline on 0300 200 7840 or by contacting the local DAERA Direct Veterinary Office.

Image © Shutterstock

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.